Breaking News Chemocetryx Inc (NASDAQ: CCXI) Rallies By Over 200% As Trial Treatment Shows Potential ChemoCentryx Inc (NASDAQ: CCXI) was one of the biggest gainers in Tuesday’s trading session. The stock shot up by 281.27% to close the day at $30.73. This followed news that the company’s treatment candidate showed potential in the treatment of